封面
市場調查報告書
商品編碼
1333464

生物活性傷口管理的全球市場

Bioactive Wound Management

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 403 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球生物活性傷口管理市場將達到 35 億美元

在Covid-19後商業環境發生變化的情況下,全球生物活性傷口管理市場預計2022年為18億美元,到2030年將修正為35億美元,分析期為2022-2030年年複合成長率為8.7 %。海藻酸鹽是本報告分析的細分市場之一,預計複合年複合成長率7.6%,到分析期結束時將達到 10 億美元。鑑於大流行後的持續復甦,未來八年膠原蛋白敷料領域的年複合成長率將調整為 9.8%。

美國市場預計將成長6.945億美元,中國年複合成長率為10.5%

到 2022 年,美國生物活性傷口管理市場預計將達到 6.945 億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到3.134億美元,2022年至2030年復合年成長率為10.5%。其他值得注意的區域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 7.1% 和 7.5%。在歐洲,德國預計年複合成長率約為 8.4%。

受訪企業示例

  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • ConMed Corporation
  • Coloplast Group
  • Advanced Medical Solutions Group PLC
  • AlloSource
  • Collagen Matrix, Inc.
  • Braile Biomedica
  • ACell Inc.
  • Axio Biosolutions Private Limited
  • Biovotec AS
  • Argentum Medical LLC(Silverlon)
  • Avery Dennison Medical
  • Bio-medical Carbon Technology Co., Ltd.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 宏觀經濟成長的驅動力
  • 宏觀經濟成長的驅動力
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP16205

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Bioactive Wound Management Market to Reach $3.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Bioactive Wound Management estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2022-2030. Alginates, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Collagen-Based Dressings segment is readjusted to a revised 9.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $694.5 Million, While China is Forecast to Grow at 10.5% CAGR

The Bioactive Wound Management market in the U.S. is estimated at US$694.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$313.4 Million by the year 2030 trailing a CAGR of 10.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.1% and 7.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Select Competitors (Total 90 Featured) -

  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • ConMed Corporation
  • Coloplast Group
  • Advanced Medical Solutions Group PLC
  • AlloSource
  • Collagen Matrix, Inc.
  • Braile Biomedica
  • ACell Inc.
  • Axio Biosolutions Private Limited
  • Biovotec AS
  • Argentum Medical LLC (Silverlon)
  • Avery Dennison Medical
  • Bio-medical Carbon Technology Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Review of the World Economy in 2021
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19-Led Wound Management Crisis & Patient Suffering Create Need for Effective Interventions
    • Dwindling Revenues for Wound Care Practices
    • Telemedicine, Remote Patient Monitoring Takes Center Stage
    • Influencer Market Insights
    • World Market Trajectories
    • Bioactive Wound Management - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Wounds & Wound Management: A Prelude
    • Bioactive Wound Management: A Prelude
    • Outlook
    • Healthcare Burden of Chronic Wounds and the Need for Effective Wound Management Products
    • Prevalence and Incidence of Wounds - Select Statistics
    • Global Prevalence of Wounds by Type (in Millions)
    • Global Wound Care Market: Percentage Breakdown of Spending by Wound Type
    • Healing Time by Type of Wound (in Days)
    • Chronic Wounds: Select Statistics
    • Reduced Economic Cost of Wound Care Triggers Transition to Advanced Products
    • Breakdown of Costs Associated with Wound Care
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Effective Burn Wound Management with Bioactive Dressings
    • Uptrend in Surgical Care Augurs Well for Market Growth
    • Global Surgical Procedure Volume by Procedure Type
    • Rise in Prevalence of Pressure Ulcers and the Growing Focus on Treatment Solutions
    • Pressure Ulcer Occurrence Rate Based on the Length of Surgery
    • Understanding the Wound: A Widening Area of Interest
    • Smart" Dressings Set the Road to Futuristic Wound Care
    • Startups Enter the Fray
    • Growing Focus on Reducing Hospital Stays Lends Traction
    • Technological Advancements Remain Buoyant
    • Conductive Bio-material Wound Dressings Beneficial for Wound Healing
    • Combination Dressings Emerge as a Key Trend
    • Cellulose-based Dressings Exude Immense Potential for Chronic Wound Management
    • 3D-Printed Stem Cells & Lasers to Kill Bacteria
    • New Bioactive Wound Dressings
    • Chitin, Chitosan and Derivatives
    • Bioactive Glasses Show Promising Wound Healing Outcomes
    • Rising Incidence of Diabetes and DFUs to Propel Market Growth
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • World Diabetes Prevalence (2000 - 2019)
    • COVID-19 Crisis & Restrictions Upend Care for Diabetic Foot Disease Patients
    • Growing Acceptance of Moist Wound Environment Spurs Demand for Moist Wound Dressings
    • Alginate Dressings Dominate the Market
    • Antimicrobial Dressings Find Application for Healing Wounds with High Bacterial Load
    • Multi-Drug Resistant Bacteria: A Pressing Concern
    • Tissue Engineering in Wound Care
    • Bioengineered Skin Substitutes
    • Collagen Dressings in Advanced Wound Care
  • MACRO GROWTH DRIVERS
    • Impact of Healthcare Expenditure on Market Growth
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
    • Expanding Aging Population Spurs Demand
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Obesity Levels Fuel Demand
    • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
  • MACRO GROWTH DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 3: World 14-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2016, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Alginates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Alginates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 6: World 14-Year Perspective for Alginates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Collagen-Based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Collagen-Based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 9: World 14-Year Perspective for Collagen-Based Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Antimicrobial Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Antimicrobial Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 12: World 14-Year Perspective for Antimicrobial Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 15: World 14-Year Perspective for Bioengineered Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hydrocolloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hydrocolloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 18: World 14-Year Perspective for Hydrocolloids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 21: World 14-Year Perspective for Burn Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 24: World 14-Year Perspective for Surgical Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 27: World 14-Year Perspective for Diabetic Foot Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 30: World 14-Year Perspective for Venous Leg Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 33: World 14-Year Perspective for Pressure Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 36: World 14-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 39: World 14-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 42: World 14-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2016, 2023 & 2030
    • TABLE 43: World Bioactive Wound Management Market Analysis of Annual Sales in US$ Thousand for Years 2016 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 46: USA 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 49: USA 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 52: USA 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 55: Canada 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 58: Canada 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 61: Canada 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • JAPAN
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 64: Japan 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 67: Japan 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 70: Japan 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • CHINA
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 73: China 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 76: China 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 79: China 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • EUROPE
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 82: Europe 14-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2016, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 85: Europe 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 88: Europe 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 91: Europe 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • FRANCE
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 94: France 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 97: France 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 100: France 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • GERMANY
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 103: Germany 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 106: Germany 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 109: Germany 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 112: Italy 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 115: Italy 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 118: Italy 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • UNITED KINGDOM
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 121: UK 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 124: UK 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 127: UK 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ASIA-PACIFIC
    • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Bioactive Wound Management by Product - Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 148: Rest of World 14-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Alginates, Collagen-Based Dressings, Antimicrobial Dressings, Bioengineered Skin Substitutes and Hydrocolloids for the Years 2016, 2023 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Bioactive Wound Management by Application - Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 151: Rest of World 14-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers for the Years 2016, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Bioactive Wound Management by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 154: Rest of World 14-Year Perspective for Bioactive Wound Management by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030

IV. COMPETITION